Site- and allele-specific polycomb dysregulation in T-cell leukaemia - Aix-Marseille Université Access content directly
Journal Articles Nature Communications Year : 2015

Site- and allele-specific polycomb dysregulation in T-cell leukaemia

Lydie Pradel
Bernard Malissen
Hervé Dombret


T-cell acute lymphoblastic leukaemias (T-ALL) are aggressive malignant proliferations characterized by high relapse rates and great genetic heterogeneity. TAL1 is amongst the most frequently deregulated oncogenes. Yet, over half of the TAL1+ cases lack TAL1 lesions, suggesting unrecognized (epi)genetic deregulation mechanisms. Here we show that TAL1 is normally silenced in the T-cell lineage, and that the polycomb H3K27me3-repressive mark is focally diminished in TAL1+ T-ALLs. Sequencing reveals that >20% of monoallelic TAL1+ patients without previously known alterations display microinsertions or RAG1/2-mediated episomal reintegration in a single site 5′ to TAL1. Using ‘allelic-ChIP’ and CrispR assays, we demonstrate that such insertions induce a selective switch from H3K27me3 to H3K27ac at the inserted but not the germline allele. We also show that, despite a considerable mechanistic diversity, the mode of oncogenic TAL1 activation, rather than expression levels, impact on clinical outcome. Altogether, these studies establish site-specific epigenetic desilencing as a mechanism of oncogenic activation.
Fichier principal
Vignette du fichier
ncomms7094.pdf (898.11 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-01612097 , version 1 (06-01-2020)





Jean-Marc Navarro, Aurore Touzart, Lydie Pradel, Marie Loosveld, Myriam Koubi, et al.. Site- and allele-specific polycomb dysregulation in T-cell leukaemia. Nature Communications, 2015, 6 (1), pp.6094. ⟨10.1038/ncomms7094⟩. ⟨hal-01612097⟩
404 View
138 Download



Gmail Facebook Twitter LinkedIn More